Medicinal Products

Incresync

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Incresync
Active Substance alogliptinbenzoat
pioglitazonklorid
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
ATC Code A10BD09
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Back